Survival Analysis of Patients With Transplantable Recurrent Hepatocellular Carcinoma
Author(s) -
Kelvin K. Ng
Publication year - 2008
Publication title -
archives of surgery
Language(s) - English
Resource type - Journals
eISSN - 1538-3644
pISSN - 0004-0010
DOI - 10.1001/archsurg.2007.15
Subject(s) - medicine , hepatocellular carcinoma , surgery , salvage therapy , liver transplantation , univariate analysis , percutaneous ethanol injection , hepatectomy , retrospective cohort study , carcinoma , survival rate , multivariate analysis , transplantation , radiofrequency ablation , resection , chemotherapy , ablation
There is no difference in the survival benefit between salvage liver transplant and nontransplant therapies for recurrent hepatocellular carcinoma (HCC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom